Yimmugo J Code: J1553

Drug & Product Overview

HCPCS Descriptor Injection, immune globulin (yimmugo), 100 mg

HCPCS Added Date April 1, 2026

Manufacturer Kedrion Biopharma

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Form Solution

About Yimmugo

Yimmugo is a medication aligned to the HCPCS J Code: J1553 for billing, pricing, and reimbursement purposes in the United States. Classified under Immunoglobulin, it is administered via the intravenous route and manufactured by Kedrion Biopharma.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 3 of 6 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
83372-0605-01	Yimmugo	Biotest AG	50	10000 MG / 100 ML
83372-0605-11	Yimmugo	Biotest AG	100	10000 MG / 100 ML
83372-0605-21	Yimmugo	Biotest AG	200	10000 MG / 100 ML
•••••-••••-•• Log in to view	Yimmugo
	Yimmugo
	Yimmugo

Login to view 3 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Yimmugo Pricing & Reimbursement

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Yimmugo CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Yimmugo Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Primary Humoral Immunodeficiency (PI) Primary Humoral Immunodeficiency (PI) — Measles Exposure (post-exposure) Primary Humoral Immunodeficiency (PI) — Measles Exposure (pre-exposure risk, dose increase)

Drug Class

Antigen Neutralization [MoA]Human Immunoglobulin G [EPC]Immunoglobulins [CS]Passively Acquired Immunity [PE]

Frequently Asked Questions

Is there an available Yimmugo billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for Yimmugo.

Are there any available Yimmugo patient assistance programs?

Yimmugo patient assistance information can be found through Kedrion Biopharma. Visit Here →

Where can I find Yimmugo prescribing information?

Yimmugo prescribing information can be found at the link below. Visit Here →

Where can I find Yimmugo side effect information?

Our team has not yet identified a source of side effects information for Yimmugo.

Does billing Yimmugo require JZ/JW wastage modifiers?

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.